7416 Federal Register / Vol. 86, No. 17 / Thursday, January 28, 2021 / Notices 

Delivery Consortium, Inc.’’) has filed 

written notifications simultaneously 

with the Attorney General and the 

Federal Trade Commission disclosing 

changes in its membership. The 

notifications were filed for the purpose 

of extending the Act’s provisions 

limiting the recovery of antitrust 

plaintiffs to actual damages under 

specified circumstances. Specifically, 

Sanofi, Paris, FRANCE, has been added 

as a party to this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and Subcutaneous 

Drug Development & Delivery 

Consortium, Inc. intends to file 

additional written notifications 

disclosing all changes in membership. 

On October 26, 2020, Subcutaneous 

Drug Development & Delivery 

Consortium, Inc. filed its original 

notification pursuant to Section 6(a) of 

the Act. The Department of Justice 

published a notice in the Federal 

Register pursuant to Section 6(b) of the 

Act on December 3, 2020 (85 FR 78148). 

Suzanne Morris, 

Chief, Premerger and Division Statistics 

Antitrust Division. 

[FR Doc. 2021–01895 Filed 1–27–21; 8:45 am] 

BILLING CODE 4410–11–P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—ODVA, Inc. 

Notice is hereby given that, on 

January 14, 2021, pursuant to Section 

6(a) of the National Cooperative 

Research and Production Act of 1993, 

15 U.S.C. 4301 et seq. (‘‘the Act’’), 

ODVA, Inc. (‘‘ODVA’’) has filed written 

notifications simultaneously with the 

Attorney General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, KOFLOC Corp., Kyoto, 

JAPAN; Carlo Gavazzi Ltd., Zejtun, 

MALTA; Acuity Brands, Inc., Conyers, 

GA; BBH Products GmbH, Weiden, 

GERMANY; Thermo Gamma-Metrics 

LLC, San Diego, CA; IDEM Safety 

Switches Ltd., Wigan, UNITED 

KINGDOM; Rexnord Industries, LLC, 

Milwaukee, WI; Caterpillar, Inc., 

Deerfield, IL; and AQ M–TECH AB, 

Uppsala, SWEDEN, have been added as 

parties to this venture. 

Also, SAMWON ACT Co., Ltd., 

Busan, SOUTH KOREA; and The 

Controls Group, Inc. dba Logix, 

Kirkland, WA, have withdrawn as 

parties to this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and ODVA 

intends to file additional written 

notifications disclosing all changes in 

membership. 

On June 21, 1995, ODVA filed its 

original notification pursuant to Section 

6(a) of the Act. The Department of 

Justice published a notice in the Federal 

Register pursuant to Section 6(b) of the 

Act on February 15, 1996 (61 FR 6039). 

The last notification was filed with 

the Department on September 17, 2020. 

A notice was published in the Federal 

Register pursuant to Section 6(b) of the 

Act on October 15, 2020 (85 FR 65424). 

Suzanne Morris, 

Chief, Premerger and Division Statistics 

Antitrust Division. 

[FR Doc. 2021–01894 Filed 1–27–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Border Security 

Technology Consortium 

Notice is hereby given that, on 

January 12, 2021, pursuant to Section 

6(a) of the National Cooperative 

Research and Production Act of 1993, 

15 U.S.C. 4301 et seq. (‘‘the Act’’), 

Border Security Technology Consortium 

(‘‘BSTC’’) has filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, Carahsoft Technology 

Corporation, Reston, VA; JANTEQ 

Corporation, Irvine, CA; STRAX 

Intelligence Group, Boca Raton, FL; 

goTenna, Inc., Brooklyn, NY; 

International Electronic Machines 

Corporation, Troy, NY; CellAntenna 

Corp., Coral Springs, FL; and Shield AI 

Inc., San Diego, CA, have been added as 

parties to this venture. 

Also, Bruker Detection Corporation, 

Billerica, MA; Innovative Signal 

Analysis, Richardson, TX; Copious 

Imaging LLC, Lexington, MA; IDEMIA 

National Security Solutions, LLC, 

Alexandria, VA; Passport Systems, N. 

Billerica, MA; Planck Aerosystems, Inc., 

San Diego, CA; JANTEQ Corporation, 

Irvine, CA; SRC, Inc., North Syracuse, 

NY; CUBRC, Inc., Buffalo, NY; and 

Tribalco, LLC, Bethesda, MD have 

withdrawn as parties to this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and BSTC intends 

to file additional written notifications 

disclosing all changes in membership. 

On May 30, 2012, BSTC filed its 

original notification pursuant to Section 

6(a) of the Act. The Department of 

Justice published a notice in the Federal 

Register pursuant to Section 6(b) of the 

Act on June 18, 2012 (77 FR 36292). 

The last notification was filed with 

the Department on October 21, 2020. A 

notice was published in the Federal 

Register pursuant to section 6(b) of the 

Act on November 19, 2020 (85 FR 

73751). 

Suzanne Morris, 

Chief, Premerger and Division Statistics 

Antitrust Division. 

[FR Doc. 2021–01890 Filed 1–27–21; 8:45 am] 

BILLING CODE 4410–11–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–767] 

Importer of Controlled Substances 

Application: Indigenous Peyote 

Conservation Initiative 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Indigenous Peyote 

Conservation Initiative has applied to be 

registered as an importer of basic 

class(es) of controlled substance(s). 

Refer to SUPPLEMENTAL INFORMATION

listed below for further drug 

information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before March 1, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

March 1, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Federal Register / Vol. 86, No. 17 / Thursday, January 28, 2021 / Notices 7417 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All requests for a 

hearing should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on October 15, 2020, 

Indigenous Peyote Conservation 

Initiative, 826 North FM 649, 

Hebbronville, Texas 78361, applied to 

be registered as an importer of the 

following basic class(es) of controlled 

substance(s): 

Controlled substance Drug 

code Schedule 

Peyote ....................... 7415 I 

The company plans to import Peyote 

plants for research, analytical purposes, 

and improving conservation of South 

Texas Cacti in situ. This Peyote is listed 

under drug code 7415. No other activity 

for this drug code is authorized for this 

registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–01885 Filed 1–27–21; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Federal Bureau of Investigation 

[OMB Number 1110–0073] 

Agency Information Collection 

Activities; Proposed eCollection, 

eComments Requested; Crime Data 

Explorer Feedback Survey 

AGENCY: Federal Bureau of 

Investigation, Department of Justice. 

ACTION: 60-Day notice. 

SUMMARY: The Department of Justice, 

Federal Bureau of Investigation, 

Criminal Justice Information Services 

Division, will be submitting the 

following information collection request 

to the Office of Management and Budget 

for review and approval in accordance 

with the Paperwork Reduction Act of 

1995. 

DATES: Comments are encouraged and 

will be accepted for 60 days until March 

29, 2021. 

FOR FURTHER INFORMATION CONTACT: If 

you have additional comments 

especially on the estimated public 

burden or associated response time, 

suggestions, or need a copy of the 

proposed information collection 

instrument with instructions or 

additional information, please contact 

Mrs. Amy C. Blasher, Unit Chief, 

Federal Bureau of Investigation, CJIS 

Division, Module E–3, 1000 Custer 

Hollow Road, Clarksburg, West Virginia 

26306; acblasher@fbi.gov. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the Federal Bureau of 

Investigation, including whether the 

information will have practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Evaluate how the quality, utility, and 

clarity of the information to be 

collected can be enhanced; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

1. Type of Information Collection: 

Extension of a previously approved 

collection. 

2. The Title of the Form/Collection: 

Crime Data Explorer Feedback Survey. 

3. The agency form number, if any, 

and the applicable component of the 

Department sponsoring the collection: 

There is no form number for this 

collection. The applicable component 

within the Department of Justice is the 

Criminal Justice Information Services 

Division, in the Federal Bureau of 

Investigation. 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract: Primary: Law enforcement, 

academia, and the general public. 

Abstract: This survey is needed to 

collect feedback on the functionality of 

the Crime Data Explorer in order to 

make improvements to the application. 

5. An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: The Federal Bureau of 

Investigation Uniform Crime Reporting 

Program’s Crime Data Explorer Burden 

Estimation: It is estimated the Crime 

Data Explorer will generate 200 

feedback responses per year with an 

estimated response time of two minutes 

per response. 

6. An estimate of the total public 

burden (in hours) associated with the 

collection: There are approximately 

seven hours, annual burden, associated 

with this information collection. 

If additional information is required 

contact: Melody Braswell, Department 

Clearance Officer, United States 

Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Two Constitution 

Square, 145 N Street NE, 3E.405A, 

Washington, DC 20530. 

Dated: January 25, 2021. 

Melody Braswell, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2021–01882 Filed 1–27–21; 8:45 am] 

BILLING CODE 4410–02–P 

DEPARTMENT OF JUSTICE 

Federal Bureau of Investigation 

[OMB Number 1110–0015] 

Agency Information Collection 

Activities; Proposed eCollection 

eComments Requested; Extension of a 

Currently Approved Collection; Hate 

Crime Incident Report 

AGENCY: Federal Bureau of Investigation 

(FBI), Department of Justice (DOJ). 

ACTION: 30-Day notice. 

SUMMARY: The DOJ, FBI, Criminal 

Justice Information Services (CJIS) 

Division, will be submitting the 

following information collection request 

to the Office of Management and Budget 

for review and approval in accordance 

with the Paperwork Reduction Act 

(PRA) of 1995. 

DATES: Comments are encouraged and 

will be accepted for 30 days until March 

1, 2021.